1. Home
  2. MHH vs TIL Comparison

MHH vs TIL Comparison

Compare MHH & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$5.58

Market Cap

81.7M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.37

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHH
TIL
Founded
1986
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7M
74.7M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
MHH
TIL
Price
$5.58
$8.37
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
8.9K
19.4K
Earning Date
05-15-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
0.05
N/A
Revenue
$191,371,000.00
N/A
Revenue This Year
$2.93
N/A
Revenue Next Year
$8.93
N/A
P/E Ratio
$117.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$5.67
52 Week High
$9.96
$42.75

Technical Indicators

Market Signals
Indicator
MHH
TIL
Relative Strength Index (RSI) 39.17 47.38
Support Level $5.52 $8.07
Resistance Level $8.00 $9.05
Average True Range (ATR) 0.45 0.48
MACD 0.00 -0.06
Stochastic Oscillator 16.73 51.37

Price Performance

Historical Comparison
MHH
TIL

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: